North Star Investment Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

North Star Investment Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-250	Closed	-$5K	–	1201
2022 Q1	$5K	Buy	+250	New	+$4.5K	﹤0.01%	990

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

North Star Investment Management's OCDX Position: Q2 2022 in Review

North Star Investment Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 250 shares — an estimated $5K sold.

North Star Investment Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

North Star Investment Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
North Star Investment Management sold 250 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $5K.
North Star Investment Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
North Star Investment Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on North Star Investment Management's 13F filing for Q2 2022, filed 19 Jul 2022.